How to Buy Irhythm Technologies Stock
Irhythm Technologies Inc
iRhythm Technologies, Inc. , a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States.
Irhythm Technologies stock last closed at $177.40, down 1.58% from the previous day, and has increased 96.71% in one year. It has overperformed other stocks in the Medical Devices industry by 1.35 percentage points. Irhythm Technologies stock is currently +149.86% from its 52-week low of $71.00, and -16.32% from its 52-week high of $212.00.
There are currently 32.22M IRTC shares outstanding. The market capitalization of IRTC is $5.72B. In the past 24 hours, 375,000 IRTC shares were traded.
How to Buy Irhythm Technologies Stock
Not sure how to invest in Irhythm Technologies stock? Here's how.
- Choose where to buy Irhythm Technologies stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Irhythm Technologies stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Select your method of payment and add your info.
- Evaluate Irhythm Technologies stock: The Irhythm Technologies ticker symbol is IRTC. Is Irhythm Technologies stock a good investment? Should you buy shares of IRTC? How do IRTC's underlying business fundamentals look? Do top analysts think Irhythm Technologies is a good buy? Why has IRTC's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if IRTC is a good stock to buy).
- Execute your IRTC buy order: Decide if you will purchase IRTC shares at the current market price or use a limit order to buy IRTC stock at a particular price.
- Keep tabs on your investment in IRTC: Create a watchlist to important updates regarding your position in Irhythm Technologies stock.
Step 1: Choose where to buy Irhythm Technologies stock
You will need a brokerage account to access the NASDAQ market and buy IRTC shares.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Tech to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, you need to fill out some personal details so you can invest in IRTC today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open your new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've opened your account on our top ranked stock app, you can securely and quickly fund your account:
Watch this video walkthrough if you need help transferring funds into your new brokerage account.
Step 4: Evaluate Irhythm Technologies stock
Once you have selected the best place to buy Irhythm Technologies stock, it's very important to analyze their stock prior to buying, so you truly wrap your head around the risk and opportunity.
Irhythm Technologies Metrics
Irhythm Technologies Overview
WallStreetZen was created to help average investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on IRTC's stock page.
What is the fair value of IRTC stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge IRTC's intrinsic value.
Using relative valuations methods:
- IRTC may be overvalued based on its P/B ratio of 46.89x, relative to Medical Devices industry P/B ratio of 3.83x
You can access additional valuation analysis on IRTC's stock here.
IRTC Financial Health Overview
Signs that IRTC is financially healthy:
- IRTC profit margin has gone up from -26.9% to -7.3% in the past year.
- There are more short-term assets than short-term liabilities on the IRTC balance sheet.
Signs that IRTC is not financially healthy:
- IRTC's operating cash flow of $73.88M allows it to safely service it's debt of $733.01M.
- IRTC earnings of -$37.65M is not sufficient to cover its interest payments.
- There are more long-term liabilities than short-term assets on the IRTC balance sheet.
- IRTC has a relatively high debt to equity ratio of 7.17.
- Total IRTC debt is higher than 5 years ago, relative to shareholder equity.
Is Irhythm Technologies stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 13 Wall Street analysts who give forecasts on IRTC, the consensus analyst rating on IRTC is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent IRTC Analyst Ratings
Marie Thibault, a top 16% analyst from BTIG maintains IRTC with a strong buy rating and raises their IRTC price target from $195.00 to $215.00, on Oct 31, 2025.
BTIG's Marie Thibault raised their price target on Irhythm Technologies (NASDAQ: IRTC) by 10.3% from $195 to $215 on 2025/10/31. The analyst maintained their Strong Buy rating on the stock.
iRhythm Technologies reported its Q3 2025 earnings.
The company delivered another outstanding quarter in which revenue accelerated to $192.9M, up 30.7% Y/Y, Thibault told readers.
The record quarter from Zio Monitor and Zio AT drove the $8M beat against consensus, the analyst added.
Thibault attributed the results to iRhythm Technologies' expansion in the PCP channel, increased proactive monitoring penetration at new innovative channel partners, and continued integration of Zio into EHRs.
Earnings Report
For Q3 2025, Irhythm Technologies reported:
- Loss per share of $0.06, which beat the Zacks Consensus Estimate of $(0.36) and, by 95.2%, Q3 2024’s $(1.26).
- Revenue of $192.88M, which beat the Zacks Consensus Estimate by 4.97% and, by 30.7%, Q3 2024’s $147.54M.
For FY 2025, management guided:
- Revenue of $735M to $740M.
President & CEO Quentin Blackford commented: "iRhythm delivered another quarter of strong performance, reflecting the scalability of our platform and the growing adoption of our differentiated technology across the healthcare ecosystem.
"With Q3 2025 revenue up 30.7% Y/Y, we continue to demonstrate consistent execution and durable demand across core accounts as well as continued growth into emerging innovative channel partnerships.
“Our ongoing expansion into primary care and population health programs, combined with meaningful progress in EHR integration and new clinical evidence, reinforces our leadership in proactive cardiac monitoring.
“We are advancing our innovation pipeline — including submission of our next-generation Zio MCT solution to the FDA and early work in sleep diagnostics — while driving operational efficiency and profitable growth.
“Importantly, we achieved record free cash flow generation during the quarter and anticipate this year to be free cash flow positive on an annual basis for the first time in company history.
“iRhythm’s mission remains clear: to transform cardiac care through actionable insights, empowering clinicians and improving outcomes for millions of patients worldwide."
Richard Newitter, a top 10% analyst from Truist Securities maintains IRTC with a strong buy rating and raises their IRTC price target from $175.00 to $205.00, on Oct 15, 2025.
Ryan Zimmerman, a top 11% analyst from BTIG maintains IRTC with a strong buy rating and raises their IRTC price target from $190.00 to $195.00, on Oct 13, 2025.
Mike Polark, a top 17% analyst from Baird maintains IRTC with a buy rating and raises their IRTC price target from $180.00 to $220.00, on Oct 10, 2025.
Vijay Kumar, a bottom 4% analyst from Evercore ISI Group maintains IRTC with a hold rating and lowers their IRTC price target from $185.00 to $175.00, on Oct 7, 2025.
You can dig deeper into what analysts are projecting on the Irhythm Technologies stock forecast page.
IRTC Technicals
IRTC Performance Numbers
Last year, IRTC revenue was $702.57M. During the last 5 year, IRTC's revenue has grown by 23.41% per year. This was faster than the Medical Devices industry average of 10.82%.
Dive into IRTC's earnings and revenue performance here.
Latest Insiders Trades at IRTC
In the past year, insiders at IRTC have sold more shares than they have bought.
Quentin S. Blackford, President and CEO of IRTC, was the latest IRTC insider to sell. They sold $2,571,911.28 worth of IRTC shares on Nov 3, 2025.
Dig into more about who owns IRTC shares here.
Does IRTC stock generate passive income?
No, Irhythm Technologies doesn't provide an income stream by paying out dividends.
IRTC Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your IRTC buy order
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, use a limit order.
Press the Open button and eToro will place the order.
If you require more info about investing in stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your investment in IRTC
Now that you own some shares in IRTC, you'll want to stay up-to-date on your shares.
Create a watchlist to get notified of the latest news about your IRTC stock.
IRTC Feed
How to Buy Stock in Irhythm Technologies
To reiterate, here are the 6 steps for buying Irhythm Technologies stock:
- Choose where to buy Irhythm Technologies stock
- Sign up for a brokerage account
- Put funds into your brokerage account
- Evaluate Irhythm Technologies stock
- Execute your IRTC buy order
- Keep tabs on your investment in IRTC
If you require a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Irhythm Technologies, create a watchlist today.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.